Search results for "Coronavirus"
Latest COVID-19 research on dexamethasone, hydroxychloroquine, a vaccine, tocilizumab
Peer-reviewed details on the recent trial of dexamethasone were released, and two new trials found no benefit to early treatment with hydroxychloroquine. Positive data from a phase 1 vaccine trial were also published, as was another study of tocilizumab.
https://immattersacp.org/weekly/archives/2020/07/21/1.htm
21 Jul 2020
Studies look at COVID-19 vaccine boosters; ACP, Annals forum tackles challenging clinical questions
Two Israeli studies showed that vaccine boosters reduced rates of infection and severe disease. Experts gathered for the seventh ACP and Annals of Internal Medicine virtual forum on COVID-19. The FDA authorized a monoclonal antibody for pre-exposure prophylaxis in certain patients.
https://immattersacp.org/weekly/archives/2021/12/14/1.htm
14 Dec 2021
Latest COVID-19 research looks at obesity, AKI, nursing home prescribing, symptom checkers
Acute kidney injury (AKI) may have more severe consequences after COVID-19, nursing home residents received risky drugs during the pandemic, and an online symptom checker didn't triage safely, but preprocedural COVID-19 testing showed that vaccinations reduced asymptomatic infections.
https://immattersacp.org/weekly/archives/2021/03/16/1.htm
16 Mar 2021
Latest COVID-19 research looks at antibody utility, testing strategies, risk factors
The World Health Organization also issued updated information on SARS-CoV-2 transmission.
https://immattersacp.org/weekly/archives/2020/07/14/1.htm
14 Jul 2020
Anaphylaxis appears rare with COVID-19 vaccine, alternative administration strategies considered
The CDC's monitoring system found low rates of anaphylaxis after a first dose of the Pfizer-BioNTech COVID-19 vaccine, peer-reviewed data were published on the Moderna vaccine, and alternate vaccine administration strategies were evaluated.
https://immattersacp.org/weekly/archives/2021/01/12/2.htm
12 Jan 2021
NIH adds another antibody to recommended treatments, studies look at early cases, racial disparities
Recent COVID-19 news includes a new NIH recommendation and studies of the earliest U.S. cases, an experimental inpatient drug, and potential causes of racial disparities in outcomes.
https://immattersacp.org/weekly/archives/2021/06/22/1.htm
22 Jun 2021
New research looks at COVID-19 quarantine length in asymptomatic contacts, convalescent plasma for mild disease, related health issues
Seven-day quarantine may be sufficient for contacts without symptoms, older adults with mild disease may benefit from convalescent plasma, and cardiovascular deaths increased during the early stage of the pandemic.
https://immattersacp.org/weekly/archives/2021/01/12/3.htm
12 Jan 2021
More data on risk factors for poor COVID-19 outcomes, mixed results from treatment trials
A risk calculator, genetic findings, and red blood cell distribution width helped predict severity of and death from COVID-19. Tocilizumab showed benefit, but a number of other treatments, including CPR, did not, according to recent research.
https://immattersacp.org/weekly/archives/2020/09/29/2.htm
29 Sep 2020
New ACP resources on primary care reopening and recovery available
Resuming primary care is a key priority for supporting the U.S. health care system's capacity to manage and recover from the COVID-19 pandemic.
https://immattersacp.org/weekly/archives/2020/06/02/2.htm
2 Jun 2020
Postexposure prophylaxis drug, vaccine complications, and anticoagulation in COVID-19
A monoclonal antibody combination was effective for postexposure prophylaxis and received emergency use authorization. A study investigated postvaccine myocarditis and pericarditis, and effects of full-dose anticoagulation differed by whether patients were critically ill.
https://immattersacp.org/weekly/archives/2021/08/10/1.htm
10 Aug 2021